Copertina

Chemokine activation during cellular senescence.

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Mamoor, Shahan
Natura:	Recurso digital
Pubblicazione:	Zenodo 2024
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

FCGRT functions in senescence and transformation.
di: Mamoor, Shahan
Pubblicazione: (2025)

Developmental stage-specific control of proliferation and senescence by EZH2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Gasdermin activation during lineage specification in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Xist is activated during resistance in triple negative breast cancer in vitro.
di: Mamoor, Shahan
Pubblicazione: (2025)

Fam234b is selectively activated during the first cell division of the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Adirf activation in chronic disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

Kinase activation during small molecule inhibition of the receptors for the vascular endothelial growth factors VEGFR1 and VEGFR2.
di: Mamoor, Shahan
Pubblicazione: (2025)

Ribosomal activation in TNBC resistance in vitro.
di: Mamoor, Shahan
Pubblicazione: (2025)

PAXX is activated in aging blood cells.
di: Mamoor, Shahan
Pubblicazione: (2025)

Importin 8 is activated in childhood brain cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

Leukotriene activation in the blood of humans with high CRP.
di: Mamoor, Shahan
Pubblicazione: (2025)

ALOX15B activation in ulcerative colitis.
di: Mamoor, Shahan
Pubblicazione: (2025)

Alox5 activation in the blood of humans with high CRP.
di: Mamoor, Shahan
Pubblicazione: (2025)

TSC22D4 gene activation in Crohn's Disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

NLRP11 detects activation of CIDE cell death effectors.
di: Mamoor, Shahan
Pubblicazione: (2025)

Arid5b is activated early in human embryonic development.
di: Mamoor, Shahan
Pubblicazione: (2026)

Ep300 activation defines a common epigenetic route in chronic disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

Feedback activation of VEGF-A resulting from PAX8 inhibition in cancer cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

The homeobox transcription factor TCF7 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

The homeobox transcription factor MEOX1 is activated in and likely required for metastasis to the lymph nodes in humans with breast cancer.
di: Mamoor, Shahan
Pubblicazione: (2025)

The integral membrane protein SMIM38 is transcriptionally activated in circulating tumor cells in human breast cancer in conjunction with two SMIM38-interacting proteins of undefined function, ETDA and ETDB.
di: Mamoor, Shahan
Pubblicazione: (2025)

Rip kinase expression during early development in humans.
di: Mamoor, Shahan
Pubblicazione: (2026)

Casz1 mobilization during TE lineage specification from the pluripotent state in embryonic stem cells.
di: Mamoor, Shahan
Pubblicazione: (2026)

A retrotransposon-like gene, RTL5, is modulated during differentiation of embryonic stem cells to the trophectoderm lineage.
di: Mamoor, Shahan
Pubblicazione: (2026)

MAP3K6 functions in compensatory feedback signaling during clinical interventions featuring use of the VEGF-A inhibitor bevacizumab.
di: Mamoor, Shahan
Pubblicazione: (2025)

NLRP7 engagement in transformation and etiology of chronic disease.
di: Mamoor, Shahan
Pubblicazione: (2025)

Androgen signaling has functions in lineage commitment in the human embryo.
di: Mamoor, Shahan
Pubblicazione: (2026)

Unbiased discovery of genes required for pluripotency: Terf1.
di: Mamoor, Shahan
Pubblicazione: (2026)

Major differences between HPV+ and HPV- head and neck cancer.
di: Mamoor, Shahan
Pubblicazione: (2026)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: TGFBI.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of liver metastasis: AFM.
di: Mamoor, Shahan
Pubblicazione: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: MTF1.
di: Mamoor, Shahan
Pubblicazione: (2025)

Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Pax8-as1.
di: Mamoor, Shahan
Pubblicazione: (2026)

An expression screen to identify genes important for trastuzumab resistance: Ccl19.
di: Mamoor, Shahan
Pubblicazione: (2026)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: MAT1A.
di: Mamoor, Shahan
Pubblicazione: (2025)